Cutler Group LP Selecta Biosciences Inc Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Selecta Biosciences Inc stock. As of the latest transaction made, Cutler Group LP holds 1,700 shares of SELB stock, worth $1,428. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,700

Previous 1,700 -0.0%

Holding current value

$1,428

Previous $1,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 26, 2021	BUY	$2.92 - $5.07 $292 - $507	100 Added 6.25%	1,700 $7,000
Q4 2020 Jan 21, 2021	SELL	$1.64 - $3.42 $1,804 - $3,762	-1,100 Reduced 40.74%	1,600 $4,000
Q3 2020 Oct 27, 2020	BUY	$2.18 - $2.84 $5,886 - $7,668	2,700 New	2,700 $6,000
Q4 2019 Feb 06, 2020	SELL	$1.32 - $2.47 $805 - $1,506	-610 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$1.47 - $3.06 $1,470 - $3,060	-1,000 Reduced 62.11%	610 $1,000
Q4 2018 Feb 05, 2019	BUY	$2.66 - $15.93 $4,282 - $25,647	1,610 New	1,610 $4,000

Others Institutions Holding SELB

# of Institutions

Shares Held

4.67M

Call Options Held

Put Options Held

View Full List

About SELECTA BIOSCIENCES INC

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

More about SELB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account